Skip to Main Content

Paper Details

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.
Oncotarget
23
2016
C, CCDC171, EOC, PC4 and SFRS1 Interacting Protein 1, PRE, PSIP1, Rad51 nuclear foci, SNPs, Sp1 transcription factor, TTC39B, Women, alternative promoter, carboplatin, epithelial ovarian cancer, germline single-nucleotide polymorphisms, minor allele, ovarian cancer, ovarian cancer lines, paclitaxel, patients, platinum, promoters, putative regulatory element, rs72700653, rs7874043, serous EOC, taxane, women
Author NameAffiliation
Juliet D FrenchQIMR Berghofer Medical Research Institute
Juliet D FrenchQIMR Berghofer Medical Research Institute
Sharon E JohnattyQIMR Berghofer Medical Research Institute
Yingchang LuQIMR Berghofer Medical Research Institute
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Bo GaoThe Westmead Institute for Medical Research, The University of Sydney, Westmead Hospital
Michelle J HendersonChildren's Cancer Institute Australia
Xiaoqing ChenQIMR Berghofer Medical Research Institute
Xiaoqing ChenQIMR Berghofer Medical Research Institute
Haran SivakumaranQIMR Berghofer Medical Research Institute
Haran SivakumaranQIMR Berghofer Medical Research Institute
Chen WangMayo Clinic
Diether LambrechtsVesalius Research Center, University of Leuven
Diether LambrechtsLeuven Cancer Institute, University Hospitals Leuven
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Jenny LesterWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Sandra OrsulicWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Peter A FaschingUniversity Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg
Peter A FaschingDavid Geffen School of Medicine, University of California los angeles
Marc T GoodmanSamuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center
Pamela J ThompsonSamuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center
Tanja PejovicOregon Health and Science University and Knight Cancer Institute, Oregon Health and Science University
Yukie BeanOregon Health and Science University and Knight Cancer Institute, Oregon Health and Science University
Andreas du Bois
Andreas du Bois
Brooke L FridleyUniversity of Kansas Medical Center
Joellen M SchildkrautDuke University Medical Center
Joellen M SchildkrautDuke Cancer Institute
Donal J Brennan
Andrew BerchuckDuke University Medical Center
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul HarnettCrown Princess Mary Cancer Centre and Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead Hospital
Michelle HaberChildren's Cancer Institute Australia
Ellen L GoodeMayo Clinic
Jason S LeeQIMR Berghofer Medical Research Institute
Jason S LeeQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Anna DeFazioThe Westmead Institute for Medical Research, The University of Sydney, Westmead Hospital
Anna DeFazioThe Westmead Institute for Medical Research, The University of Sydney, Westmead Hospital
Stacey L EdwardsQIMR Berghofer Medical Research Institute
Stacey L EdwardsQIMR Berghofer Medical Research Institute
  • 1 - 46

Datasets